Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q3 | – | Sell |
-251,784
| Closed | -$8.36M | – | 95 |
|
|
2017
Q2 | $8.36M | Buy |
251,784
+14,074
| +6% | +$468K | 2.5% | 14 |
|
|
2017
Q1 | $7.63M | Buy |
237,710
+85,367
| +56% | +$2.74M | 2.36% | 17 |
|
|
2016
Q4 | $5.52M | Buy |
152,343
+5,391
| +4% | +$195K | 1.84% | 27 |
|
|
2016
Q3 | $6.76M | Buy |
146,952
+629
| +0.4% | +$28.9K | 2.5% | 15 |
|
|
2016
Q2 | $7.35M | Buy |
146,323
+4,629
| +3% | +$233K | 2.85% | 12 |
|
|
2016
Q1 | $7.58M | Sell |
141,694
-5,502
| -4% | -$294K | 2.93% | 12 |
|
|
2015
Q4 | $9.66M | Buy |
147,196
+489
| +0.3% | +$32.1K | 3.67% | 3 |
|
|
2015
Q3 | $8.28M | Sell |
146,707
-25,343
| -15% | -$1.43M | 3.33% | 6 |
|
|
2015
Q2 | $10.2M | Sell |
172,050
-1,251
| -0.7% | -$73.9K | 3.53% | 3 |
|
|
2015
Q1 | $10.8M | Sell |
173,301
-805
| -0.5% | -$50.2K | 3.65% | 4 |
|
|
2014
Q4 | $10M | Buy |
174,106
+935
| +0.5% | +$53.8K | 3.09% | 8 |
|
|
2014
Q3 | $9.31M | Sell |
173,171
-480
| -0.3% | -$25.8K | 3.08% | 9 |
|
|
2014
Q2 | $9.1M | Sell |
173,651
-3,150
| -2% | -$165K | 2.94% | 11 |
|
|
2014
Q1 | $9.34M | Sell |
176,801
-51,123
| -22% | -$2.7M | 3.18% | 8 |
|
|
2013
Q4 | $9.14M | Buy |
227,924
+9,173
| +4% | +$368K | 3.17% | 10 |
|
|
2013
Q3 | $8.26M | Buy |
218,751
+11,515
| +6% | +$435K | 3.19% | 8 |
|
|
2013
Q2 | $8.12M | Buy |
+207,236
| New | +$8.12M | 3.38% | 8 |
|